Interferential Current and Transcutaneous Electrical Nerve Stimulation for Pain After Cesarean Section
IC-TENS-CS
Comparison of the Effects of Interferential Current and Transcutaneous Electrical Nerve Stimulation on Pain Following Cesarean Section
1 other identifier
interventional
54
1 country
1
Brief Summary
This study aims to compare the immediate and short-term effects of interferential current therapy and conventional transcutaneous electrical nerve stimulation (TENS) with placebo stimulation on pain and postpartum comfort following cesarean section. A total of 54 primiparous women aged 18-40 years will be randomly assigned to an interferential current, TENS, or placebo group. Each intervention will be administered for 30 minutes. Pain intensity at rest and during in-bed activities will be assessed before the intervention, immediately after the intervention, and at 1 and 2 hours after the intervention. Postpartum comfort, treatment satisfaction, anxiety, and depression will also be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2026
CompletedFirst Submitted
Initial submission to the registry
September 22, 2026
CompletedFirst Posted
Study publicly available on registry
September 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
October 2, 2026
September 1, 2026
11 months
September 22, 2026
September 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pain Intensity at Rest
Pain intensity at rest will be assessed using a 10-cm Visual Analog Scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity. Changes from baseline will be compared among the three groups.
Baseline, immediately after the 30-minute intervention, 1 hour after the intervention, and 2 hours after the intervention
Secondary Outcomes (2)
Change in Postpartum Comfort
Baseline and 2 hours after the intervention
Treatment Satisfaction
Immediately after the intervention, 1 hour after the intervention, and 2 hours after the intervention
Other Outcomes (1)
Association Between Psychological Symptoms and Change in Pain Intensity
From baseline to 2 hours after the intervention
Study Arms (3)
Conventional TENS
ACTIVE COMPARATORParticipants will receive one 30-minute session of conventional transcutaneous electrical nerve stimulation following cesarean section.
Interferential Current Therapy
EXPERIMENTALParticipants will receive one 30-minute session of interferential current therapy following cesarean section.
Placebo Stimulation
PLACEBO COMPARATORParticipants will receive one 30-minute session of placebo electrical stimulation following cesarean section.
Interventions
Interferential current therapy will be applied for 30 minutes using a fixed frequency of 100 Hz. Four self-adhesive electrodes will be positioned around the cesarean incision in a crossed arrangement. Current intensity will be increased to a strong but comfortable sensory level and adjusted during the session to maintain the same sensation.
The electrodes and stimulation device will be applied in the same position and for the same 30-minute duration as in the active intervention groups; however, no electrical current will be delivered.
Conventional TENS will be applied for 30 minutes at a frequency of 125 Hz and a pulse duration of 60 microseconds. Four self-adhesive electrodes will be positioned around the cesarean incision. Current intensity will be increased to a strong but comfortable sensory level and adjusted during the session to maintain the same sensation.
Eligibility Criteria
You may qualify if:
- Women aged 18 to 40 years
- Ability to read, write, and communicate in Turkish
- Primiparous women
- Having delivered a healthy singleton infant by cesarean section
- No additional surgical procedure or complication during or after the cesarean section
You may not qualify if:
- Impaired orientation or cooperation
- History of systemic disorders, including hyperglycemia or hypertension, gastrointestinal disorders, or urogynecological disorders
- Previous abdominal surgery
- Neurological, orthopedic, cardiopulmonary, or other health conditions that may prevent mobilization or ambulation
- Previous experience with transcutaneous electrical nerve stimulation or interferential current therapy
- Contraindications to electrical stimulation, including sensory loss at the application site, dermatological problems or allergic reactions at the application site, or a cardiac pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dilara Özen Oruklead
Study Sites (1)
Menteşe State Hospital
Muğla, 48000, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dilara Özen Oruk, PhD
Muğla Sıtkı Koçman University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will not be informed of their treatment allocation. Outcome assessments will be performed by a physiotherapist who is blinded to group allocation. The physiotherapist administering the interventions will not be blinded because the stimulation parameters must be adjusted during treatment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Assistant, PhD
Study Record Dates
First Submitted
September 22, 2026
First Posted
September 29, 2026
Study Start
March 4, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
October 2, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available because the dataset contains sensitive obstetric and health information, and public data sharing was not included in the informed consent process.